Glaukos Corporation
At a glance
EmployeesNot reported
In business sinceNot reported
Industry
HeadquartersAliso Viejo, CA
US patents110
SAM.gov UEIM77LMBPAZLL9
CAGE code8QAP5
Incorporated inDE
LEI5299004JA1LHE21M6T14
- treatment
- ophthalmic diseases
- KXL System
- Riboflavin Family
Named on the company’s own website, read JUL 29, 2026
What they make
Open positions
Openings read from Glaukos Corporation’s own job board on Oracle Recruiting, last checked NOV 1, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Patient Advocacy and Access ManagerGermany; Switzerland; United Kingdom · posted OCT 29, 2026
- Pharmaceutical/Biologics R&D Quality LeadGlaukos Corporation · Aliso Viejo, CA, United States · posted OCT 29, 2026
- Sr. Quality EngineerBurlington, MA, United States · posted OCT 27, 2026
- Area Director, Interventional Glaucoma (SoCal)United States · posted OCT 27, 2026
- Interventional Glaucoma Business ManagerUnited States; Memphis, TN, United States; Little Rock, AR, United States; Jackson, MS, United States · posted OCT 23, 2026
- Area Director, Interventional GlaucomaUnited States; Los Angeles, CA, United States; San Diego, CA, United States; Irvine, CA, United States; Ventura, CA, United States · posted OCT 23, 2026
- Clinical Research Associate - Multiple Levels AvailableUnited States · posted OCT 22, 2026
- Regional Business Manager - BrazilBrazil · posted OCT 16, 2026
- Glaucoma Reimbursement LiaisonAtlanta, GA, United States · posted OCT 15, 2026
- Business Systems Manager-QualityGlaukos Corporation · Aliso Viejo, CA, United States; Burlington, MA, United States · posted OCT 14, 2026
36 more on the company’s board
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
110 US patents granted 2003–2025, 34 of them in the five years to SEP 2025, including 8 design patents.
Medical technology 73Pharmaceuticals 29
- Controlled drug delivery ocular implants and methods of using sameUS 12,427,057 · granted SEP 30, 2025
- Drug eluting ocular implantUS 12,419,783 · granted SEP 23, 2025
- Ophthalmic topical cream compositions and methodsUS 12,414,938 · granted SEP 16, 2025
- Systems and methods for delivering multiple ocular implantsUS 12,414,798 · granted SEP 16, 2025
- Drug eluting ocular implants and methods of treating an ocular disorderUS 12,376,989 · granted AUG 5, 2025
Newest 5 shown · Granted to Glaukos Corporation · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Glaukos Corporation | Aliso Viejo | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.